Literature DB >> 18460756

Polyvinyl alcohol-glycine composite membranes: preparation, characterization, drug release and cytocompatibility studies.

Kunal Pal1, Ajit Kumar Banthia, Dipak K Majumdar.   

Abstract

The purpose of this study was to prepare a polyvinyl alcohol-glycine composite membrane to deliver glycine directly to a site of injury to be utilized for the synthesis of collagen for complete healing of a wound. Polyvinyl alcohol (PVA) and glycine (Gly) blended composite membranes, with different PVA:glycine ratios (1:0.2, 1:0.4, 1:0.6, 1:0.8 and 1:1 w/w), were prepared using a conventional solution casting technique. Various characterizations namely XRD, DSC, tensile tests and glycine release studies of the membranes were done. MTT assay was done to ensure cytocompatibility of the PVA-Gly (1:0.6) membrane using L929 fibroblast cells and mice splenocytes. XRD study indicated dispersion of crystalline glycine in a relatively less crystalline PVA in the membrane. FTIR spectra showed shifting of the hydroxyl peak of PVA from 3430 cm(-1) to 3171 cm(-1) and 3010 cm(-1) in the membranes, indicating intermolecular hydrogen bonding and viscosity measurements of various mixtures of PVA-Gly in solution also supported the same. DSC indicated no interaction between PVA and Gly. It was found that the tensile strength of the composite membrane decreased with the increase in glycine content though there was a marginal increase in the strength when the PVA:Gly ratio was 1:1. Further increase in the Gly content in the membranes was not possible as a solid physical gel was formed while mixing the solutions of PVA and Gly. Gly release from the membrane was immediate following diffusion-controlled Fickian kinetics. The relative cell proliferation of the L929 cells and mice splenocytes were found to be 2.38 and 2.24, respectively, indicating the cytocompatibility of the membrane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18460756     DOI: 10.1088/1748-6041/1/2/001

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  6 in total

1.  Genipin-Crosslinked Gelatin-Based Emulgels: an Insight into the Thermal, Mechanical, and Electrical Studies.

Authors:  Sarada P Mallick; Sai S Sagiri; Vinay K Singh; Beauty Behera; A Thirugnanam; Dillip K Pradhan; Mrinal K Bhattacharya; Kunal Pal
Journal:  AAPS PharmSciTech       Date:  2015-03-14       Impact factor: 3.246

2.  Chitosan-based electrospun nanofibrous mats, hydrogels and cast films: novel anti-bacterial wound dressing matrices.

Authors:  Sohail Shahzad; Muhammad Yar; Saadat Anwar Siddiqi; Nasir Mahmood; Abdul Rauf; Zafar-ul-Ahsan Qureshi; Muhammad Sabieh Anwar; Shahida Afzaal
Journal:  J Mater Sci Mater Med       Date:  2015-02-26       Impact factor: 3.896

3.  Composite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs.

Authors:  Marziyeh Jannesari; Jaleh Varshosaz; Mohammad Morshed; Maedeh Zamani
Journal:  Int J Nanomedicine       Date:  2011-05-19

4.  Biocompatibility and toxicity of poly(vinyl alcohol)/N,O-carboxymethyl chitosan scaffold.

Authors:  Tunku Kamarul; G Krishnamurithy; Noman D Salih; Nurul Syuhada Ibrahim; Hanumantha Rao Balaji Raghavendran; Abdul Razzaq Suhaeb; D S K Choon
Journal:  ScientificWorldJournal       Date:  2014-09-15

Review 5.  Advanced Analgesic Drug Delivery and Nanobiotechnology.

Authors:  Nicoleta Stoicea; Juan Fiorda-Diaz; Nicholas Joseph; Muhammad Shabsigh; Carlos Arias-Morales; Alicia A Gonzalez-Zacarias; Ana Mavarez-Martinez; Stephen Marjoribanks; Sergio D Bergese
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

6.  Smart nano-in-microparticles to tackle bacterial infections in skin tissue engineering.

Authors:  Marco Ruggeri; Barbara Vigani; Cinzia Boselli; Antonia Icaro Cornaglia; Daniele Colombo; Rita Sànchez-Espejo; Elena Del Favero; Narcisa Mandras; Janira Roana; Lorenza Cavallo; Laura Cantù; Cesar Viseras; Silvia Rossi; Giuseppina Sandri
Journal:  Mater Today Bio       Date:  2022-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.